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http://www.biomedcentral.com/1471-2164/15/270RESEARCH ARTICLE Open AccessMycobacterium leprae genomes from a British
medieval leprosy hospital: towards understanding
an ancient epidemic
Tom A Mendum1*, Verena J Schuenemann2, Simon Roffey3, G Michael Taylor1, Huihai Wu1, Pushpendra Singh4,
Katie Tucker3, Jason Hinds5, Stewart T Cole4, Andrzej M Kierzek1, Kay Nieselt6, Johannes Krause5
and Graham R Stewart1Abstract
Background: Leprosy has afflicted humankind throughout history leaving evidence in both early texts and the
archaeological record. In Britain, leprosy was widespread throughout the Middle Ages until its gradual and
unexplained decline between the 14th and 16th centuries. The nature of this ancient endemic leprosy and its
relationship to modern strains is only partly understood. Modern leprosy strains are currently divided into 5
phylogenetic groups, types 0 to 4, each with strong geographical links. Until recently, European strains, both
ancient and modern, were thought to be exclusively type 3 strains. However, evidence for type 2 strains, a group
normally associated with Central Asia and the Middle East, has recently been found in archaeological samples in
Scandinavia and from two skeletons from the medieval leprosy hospital (or leprosarium) of St Mary Magdalen, near
Winchester, England.
Results: Here we report the genotypic analysis and whole genome sequencing of two further ancient M. leprae
genomes extracted from the remains of two individuals, Sk14 and Sk27, that were excavated from 10th-12th century
burials at the leprosarium of St Mary Magdalen. DNA was extracted from the surfaces of bones showing osteological
signs of leprosy. Known M. leprae polymorphisms were PCR amplified and Sanger sequenced, while draft genomes
were generated by enriching for M. leprae DNA, and Illumina sequencing. SNP-typing and phylogenetic analysis of
the draft genomes placed both of these ancient strains in the conserved type 2 group, with very few novel SNPs
compared to other ancient or modern strains.
Conclusions: The genomes of the two newly sequenced M. leprae strains group firmly with other type 2F strains.
Moreover, the M. leprae strain most closely related to one of the strains, Sk14, in the worldwide phylogeny is a
contemporaneous ancient St Magdalen skeleton, vividly illustrating the epidemic and clonal nature of leprosy at
this site. The prevalence of these type 2 strains indicates that type 2F strains, in contrast to later European and
associated North American type 3 isolates, may have been the co-dominant or even the predominant genotype at
this location during the 11th century.
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Leprosy has been known since the earliest recorded times,
with references in ancient texts [1] and paleopathological
evidence in the archaeological record dating back at least
4000 years [2]. In Britain, evidence for leprosy has been
recorded from as early as the 4th century AD [3] but is
thought to have been particularly prevalent between the
11th and 14th centuries, as evidenced by a rise in the num-
ber of active leprosy hospitals known as leprosaria [4].
However, by the end of this period, leprosy was declining
such that leprosaria were being abandoned or put to other
uses. Firstly in southern Britain but later in regions further
to the north, until by the 18th century leprosy was only re-
corded in the far northern isles of Shetland, the last sufferer
dying in the Edinburgh Infirmary in 1798 [5]. This decline
in the prevalence of leprosy was reflected throughout Eur-
ope and remains an intriguing feature of infectious disease
history for which there is no clear reason. Although leprosy
is now rare in Europe, it remains a significant disease in
many parts of the world with approximately 220,000 new
cases in 2011 [6]. Despite the use of multi-drug therapy
against leprosy since the 1980s, the prevalence of the dis-
ease remains stubbornly high in many areas. A wider un-
derstanding of the origins and history of leprosy, including
why leprosy died out in Europe, may help to develop more
effective strategies for controlling the modern disease.
Leprosy genomes show an unusual degree of conserva-
tion with strains being >99.9% identical. Only 807 poly-
morphic sites are recorded across all known strains [7],
most of which are Single Nucleotide Polymorphisms
(SNPs), with some Variable Nucleotide Tandem Repeats
(VNTRs) [8]. This is despite the presence of more than
1300 pseudogenes, equating to 41% of the genome [9]. A
subset of these polymorphic loci were used to develop a
molecular typing scheme and to generate a phylogeny
for M. leprae. This predicted an ancestral strain, thought
to have a genotype between that of modern type 2 and
type 3 strains, originating in East Africa approximately
100,000 years ago [8]. From there, leprosy appeared to
have disseminated across the world along routes of hu-
man migration and trade, with type 1 strains dominating
in Southeast Asia, type 3 s in the Near East and Europe,
type 3Is in Northwestern Europe and ultimately in
North America and type 4 s in West Africa and later
Brazil [8]. Recently, new data have challenged this
interpretation, with an apparently more basal group,
type 0, being identified in patients from China and New
Caledonia [7].
In an effort to build a more comprehensive and accurate
history for leprosy that better informs our understanding of
its origins and macroecology, we and others have been
studying DNA from ancient M. leprae infections. Leprosy
is unusual in that multibacillary infection causes patho-
logical changes of the bone, such that ancient infectionscan be retrospectively identified from skeletal remains.
Using SNP typing and whole genome sequencing of DNA
from such lesions, we have recently been able to re-assess
the genetic history of leprosy and demonstrate that
1000 years ago European leprosy was caused by strains that
group with type 2 and type 3 strains [7,10] and that a most
recent common ancestor of all extant and ancient M. leprae
existed only 1400 to 2700 years ago [7].
In this study we extend this work to gain further insights
into the molecular epidemiology of European medieval
leprosy. By sequencing the genomes of two further M.
leprae strains from individuals interred at the leprosarium
of St Mary Magdalen, Winchester, England, during the sec-
ond half of the 11th century we can begin to understand in
more detail the epidemiology of M. leprae at this site [11].
Results
Archaeology and osteology
Excavations at St Mary Magdalen, Winchester, are amongst
the most extensive of any British leprosy hospital to date
[11,12]. The hospital is one of the earliest such institutions
known in Britain and, as such, provides insights into both
early institutional care and the nature and status of such
communities at a relatively early date. Such hospitals may
well have been a model for succeeding charitable institu-
tions of social care. Thirty-eight burials have been exca-
vated from the site, of which 33 (87%) show osteological
signs of leprosy, a much higher percentage than observed
in other British material. Of these, five M. leprae strains
have been SNP genotyped (Sk2, Sk7, Sk8, and Sk14,
and Sk19) [10] and 2 whole genomes (Sk2 and Sk8) se-
quenced [7].
The current study focuses on typing a further burial,
Sk27, and generating whole genome sequences of the M.
leprae from both Sk14 and Sk27. Both were excavated from
the earlier and more northern of two cemeteries at the site
(together with skeletons Sk7, Sk8, Sk9 and Sk19 [10]).
Based upon comparative and diagnostic material this ceme-
tery was thought to have been in use primarily in the
decades immediately following the Norman Conquest, be-
tween 1070 AD and 1100 AD. This interpretation was con-
firmed by 14C dating, with dates of between 940 cal AD
and 1160 cal AD [11]. Sk14 and Sk27 were 14C dated to be-
tween 955–1033 cal AD (WK 28629) and 1020–1162 cal AD
(SUERC-39676), respectively.
The remains of Sk14 are those of an adolescent,
probably male, displaying clear pathological features
of leprosy: circumferential wasting of the foot phalan-
ges, loss of bone of the distal ends of the distal foot
phalanges, porosity of the shafts of the metatarsals
and porous, woven and compact bone on the shafts
of the fibulae, thinning of the palate and nasal bones
and rounding of the margins of the nasal aperture
[13]. In contrast, Sk27 was a middle-aged adult, with
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sions. Indeed, Sk27 was originally identified as a pos-
sible control, non-lepromatous skeleton and only on
closer examination was porosity and resorption of
bone noted on the dorsal surface of the distal ends of
the distal foot phalanges, particularly those for the
first metatarsal. The grave of Sk27 was also notable
for containing a scallop shell (Figure 1), indicating
that the remains are likely those of a pilgrim who
had completed the Way of St James to the Cathedral
of Santiago de Compostela in Galicia, Spain [11].Confirmation that skeleton Sk27 had been infected with
M. leprae
Samples of bone from Sk27 were scraped from the
rhino-maxillary area under clean and controlled con-
ditions using disposable gloves, scalpels and tubes. A
control sample was taken from around the vomer
(the thin bone that separates the nostrils) of a skel-
eton, Sk12, which showed no osteological evidence of
M. leprae. The vomer is a site that often has a high
M. leprae burden in lepromatous leprosy, and so is a
good site from which to isolate M. leprae DNA. The
presence of M. leprae DNA in the Sk14 extract was
previously confirmed by real-time PCR using primers
for the multicopy RLEP and the single copy locus,
ML1795 (encoding the 18 kDa antigen), both of
which gave single bands of the expected size (111 bp
and 114 bp, respectively) [13]. The presence of M.
leprae DNA in extracts from SK27 was similarly con-
firmed by PCR. PCR for the multicopy M. tubercu-
losis loci IS1081 gave no products (79 bp expected)
for either sample, indicating an absence of tubercu-
losis. The control sample Sk12 gave no products with
primers for loci of either M. leprae or M. tubercu-
losis, indicating that contamination of the samples
from extraneous sources or cross-contamination be-
tween the samples was negligible.Figure 1 The burial of Sk27 showing the associated scallop shell.Whole genome sequencing of M. leprae genomes from
skeletons SK14 and Sk27
DNA from skeletons Sk14 and Sk27 was amplified,
enriched for M. leprae sequences using microarrays, and
sequenced as described previously for Sk2 and Sk8 [7].
Details of the read depths, their alignment to the M.
leprae TN reference genome and percentage genome
coverage are given in Table 1. After quality controls less
than 1% of the sequence reads aligned with human
DNA, even in the control sample Sk12, only 1.8% of
reads aligned to human DNA.
The control sample, Sk12, was characterized by very
low coverage of the M. leprae genome, punctuated by
short regions with high coverage and high diversity.
This is consistent with a sample containing little or
no M. leprae sequence, but with some carry-over of
DNA from environmental organisms. This again con-
firms that there was little or no cross-contamination
between samples or from modern M. leprae DNA
during the sample preparation. Many of the reads
that were retrieved from Sk12 had similarity to envir-
onmental organisms that contain genomic regions
that are likely to be conserved across mycobacteria-
ceae and beyond. Such regions apparently have suffi-
cient similarity to the microarray probes to hybridize,
particularly in the absence of competing M. leprae
DNA, but are sufficiently dissimilar to generate the
high diversity observed. Regions with high coverage
included approximately 50 genes such as rpoB, tuf,
fusA and certain smaller regions within genes that
often represent conserved motifs, for example within
ABC transporters. Base calls from regions with high
coverage in the control sample were not considered
reliable and were discounted from the data.
Sanger sequencing of targeted SNPs (Table 2) was in
agreement with Illumina sequencing so validating both typ-
ing and sequencing methods. Analysis of VNTR genotypes
was not possible for either Sk14 or Sk27 as insufficient
numbers of reads spanned the ML0058c (21–3) region,
Table 1 Details of the skeletons excavated from St Mary Magdalen, Winchester
Skeleton Leprosy-like pathology Fold coverage (depth) Percent coverage (>4 reads) 14C date (cal AD, 95% probability)
Sk2 Feet, cranium 14.9 92.9 1268-1283
Sk8 Limbs, cranium 20.0 96.4 1010-1160
Sk12 None 0.39 0.99 nd
Sk14 Limbs, feet, cranium (extensive) 26.6/44.8* 98.9/98* 955-1033
Sk27 Feet (minimal) 11.9/6.7* 80.0/41.9* 1020-1162*
Details of the skeletons excavated from St Mary Magdalen, Winchester, and the whole genome sequence analysis of their associated M. leprae strains carried out
at the University of Surrey and the University of Tübingen, respectively.
*presented in this study, other details were previously published in Schuenemann et al., 2013 [7].
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(GTA)9 had high coverage in the Sk12, the control sample,
and so were deemed unreliable.
Analysis of the ancient M. leprae genomes
We have previously used PCR and Sanger sequencing of
a subset of SNPs [8] to genotype the M. leprae from
Sk14 as type 2F [10]. Using identical methods, we also
identified Sk27 as a type 2F strain (Table 2).
Independent analysis of the sequence reads at the Univer-
sity of Tübingen and the University of Surrey (Table 1),
generated differing values for coverage and read depth.
However, both centres reconstructed very similar genomes
with only a single SNP discrepancy (not included in subse-
quent analysis) between the comparable datasets. Compari-
son of the Sk14 and Sk27 M. leprae genomes with other
modern and ancient genomes identified the presence of
very few novel polymorphs (Additional file 1: Table S1).
Sk14 contained 3 novel indels, all of which were in pseudo-
genes, and 3 novel SNPs, only one of which was non-
synonymous, encoding a change of Gly163 to valine in
hypothetical protein ML1637. Sk27 had a single novel syn-
onymous SNP and no identifiable novel indels. Phylogen-
etic analysis generated trees comparable to those of
Schuenemann et al. [7] and placed Sk14 and Sk27 in the
highly conserved type 2F branch of M. leprae (Figure 2 and
Additional file 2: Figure S1). It is notable that the strain
most closely related to Sk14 is another isolate from
Winchester, Sk8, described in our previous studies [7,10].
Discussion
The history of leprosy in Europe is dominated by a
drawn-out epidemic that may have lasted a millennium,
but peaked between the 11th and 14th centuries before
declining during the following centuries. In other partsTable 2 Genotyping of M. leprae strains from Sk14 and Sk27
SNP loci (nucleotide positions relate to TN g
14676 1642875 2935685 1133492 7614
Sk27 C T A T C
Sk14 C T A T C
Type 2of the world the incidence of leprosy has remained high
despite the administration of multi-drug chemotherapy.
Understanding the origins and macroecology of leprosy
worldwide, and specifically why it declined in Europe,
may help in the development of improved control strat-
egies against the endemic worldwide leprosy of today.
Ancient DNA can be uniquely useful in constructing
and assessing models of pathogen evolution [14-16] and
macroecological patterns of infection. This is particularly
so for M. leprae, whose extremely limited genotypic
diversity has facilitated the development of models
describing the evolution of modern strains and their
historic worldwide dissemination. To more fully inform
these models and to capture the diversity of M. leprae
we have begun a bioarchaeology program of research
to sequence and reconstruct the genomes of ancient
M. leprae that infected medieval people at the site of the
leprosarium of St Mary Magdalen, at Winchester,
in southern Britain [7]. Here we continue our char-
acterization of these M. leprae strains and present two
new 1000 year old mycobacterial genomes, which in
combination with previous samples, allow us to describe,
in detail, the historical epidemiology of leprosy at this
location across the centuries.
Rather than reveal a greater diversity of mycobacterial
strains, the genomes that we present are striking in their
similarity to modern M. leprae, providing further confirm-
ation that the medieval European leprosy epidemic involved
strains almost identical to those that today infect people in
other parts of the world. It could be argued that this lack of
diversity is an artifact of enriching the ancient DNA for M.
leprae sequence using microarrays based upon modern
M. leprae genomes, potentially allowing genomic re-
arrangements or insertions to go undetected. However,
such a scenario would seem unlikely. Firstly, these samplesby SNP analysis
enome, pre correction) Indel (copy no.) 17915
1113923 1104235 3102787
A C C 2
A C C 2
F
TN (India, 1990)
Thai53  (Thailand, 1982)
S2 (Antilles, 1995)
S11 (India,  1990)
3077 (Sweden, 1032-1155 cal AD)
Sk27 (UK, 1020-1162 cal AD)
Refshale_16 (Denmark, 1046-1163 cal AD)
Sk8 (UK, 1010-1160 cal AD)
Sk14 (UK, 995-1033 cal AD)
Jorgen_625 (Denmark, 1293-1386 cal AD)
Sk2 (UK, 1268-1283 cal AD)
NHDP63 (US, 1996)
S13 (Mali, 2012)
Br4923 (Brazil, 1996)
S14 (Mali, 2012)
S9 (New Caledonia, 1996)
S10 (China, 2006)
100
100
72
100
96
99
91
100
69
89
22
88
89
31
0.02
Branch 
4
Branch 
3
Branch 
2
Branch 0
Branch 1
Figure 2 Phylogenetic relationships between modern and ancient M. leprae. A maximum likelihood tree describing the relationship
between Sk14, Sk27 and other ancient (in bold) and modern M. leprae genomes [7]. Locations and dates (14C estimates or year of isolation) are
given in brackets. Groupings are derived from Schuenemann et al. [7]. The position of Sk27 is poorly defined but is clearly within group 2 and
closely related to other ancient genomes.
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assembled genomes, both ancient and modern [7-9], none
of which have alternative genome architectures. Secondly,
we would expect any such changes in genome architecture
to be observable in the data as apparent indels at the ends
of sequence reads, each representing the boundaries of any
such re-arrangement. No such indels were identified in the
data. This leaves us to conclude that these ancient strains
were indeed highly similar to modern strains and, therefore,
the diminishing incidence of leprosy in Europe was not
caused by the evolution of M. leprae to a distinct genotypes
that was less virulent or less transmissible. A more probable
explanation is that changing social conditions reduced the
rate of transmission and that concomitant epidemics of
tuberculosis and Yersinia pestis (plague) resulted in high
rates of mortality in leprosy infected individuals, effectively
reducing the reservoir of transmissible infection [17] and
hastening the selection of resistant host genotypes in the
human population. A further factor may have been an in-
crease in immunological resistance to leprosy in the popu-
lation associated with exposure to the increasing levels of
tuberculosis [8,18].
The genomes of the M. leprae from skeletons Sk14
and Sk27 group firmly with other type 2F strains. More-
over, the most closely related M. leprae strain in theworldwide phylogeny (Figure 2) to Sk14 is another ancient
St Magdalen skeleton, Sk8, described in our previous stud-
ies [7,10]. Both individuals were contemporaneous children
or adolescents, illustrating vividly the epidemic and con-
served nature of leprosy at this site.
Until recently, type 2M. leprae had only been identified
in Asia and the Near East. It had been assumed that these
type 2 strains gave rise to type 3 strains and moved
with human migration to become the archetypal strains in
Western Europe [8]. However, we and others have shown
the presence of type 2 strains in Europe [10,19] in the 11th
and 12th centuries, alongside the more typical type 3K, 3M
and 3I strains [8,20] (Table 3). It is now clear that, at least
at Winchester, type 2F strains, rather than being unusual,
may well have been a co-dominant or even the predomin-
ant strain during the 11th century. The lack of type 2F
strains and presence of type 3I strains in later burials both
here at Winchester, and elsewhere in Europe [21] may be
indicative of the shift away from type 2F strains towards the
type 3 strains of leprosy typically seen in later European
and North American (thought to be epidemiologically re-
lated to European strains [7,8]) strains. It is difficult, from
these data, to determine whether the type 2F strains identi-
fied at St Mary Magdalen were truly endemic to the area,
or whether they were a relatively new introduction, possibly
Table 3 Details of ancient M. leprae strains with known genotypes, ordered by date
Location Case Date (century or cal AD) Type Reference
Ustyurt plateau, Uzbekistan 5b 1st-4th C 3L [22]
Dakhleh Oasis, Egypt K2-B116 4th-5th C 3K/L/M [8]
Kiskundorozsma, Hungary KD271 7th C 3K [8]
Kovuklukaya, Turkey KK20/1 8th-9th C 3K [8]
Radasinovic, Croatia 2A 8th-9th C 3 [21]
Radasinovic, Croatia 3A 8th-9th C 3 [21]
Norwich, UK 11287 10th-11th C 3 [21]
Püspökladany, Hungary 222 10th C 3K [8]
Püspökladany, Hungary 503 11th C 3M [8]
Norwich, UK 11503 10th-11th C 3 [21]
Norwich, UK 11784 10th-11th C 3 [21]
Winchester, UK Sk14 995-1033 AD 2F [7,10], this study
Winchester, UK Sk8 1010 -1160 AD 2F [10]
Winchester, UK Sk27 1020-1162 AD 2F this study
Sigtuna, Sweden 3077 1032-1155 AD 2F [7,19]
Refshale, Denmark Refshale_16 1046-1163 AD 2F [7]
Winchester, UK Sk7 10th-12th C 3I [10]
Winchester, UK Sk19 10th-12th C 3I [10]
Sigtuna, Sweden 3092 10th-14th C 2F [19]
Sigtuna, Sweden 3093 10th-14th C 3I [19]
Winchester, UK Sk2 1268-1283 AD 3I [7,10]
Odense, Denmark Jorgen_625 1293-1386 AD 3I [7]
Ipswich, UK 1914 1263-1538 AD 3I variant [13,21]
Odense, Denmark G483 1275-1560 AD 3I/J [21]
Aomori, Japan sk26 18th-19th C 1 [23]
Adapted from Monot et al. [8].
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graphically illustrated by the presence of a scallop shell in
the grave of Sk27. Whatever their origins, the apparent dis-
placement of type 2F strains by type 3 strains in later arch-
aeological and contemporary samples is unlikely to have
been due to a selective pressure as there are very few gen-
etic differences between strains, and those that are present
are not predicted to encode phenotypic changes. An alter-
native model describing a shift towards a type 3 European
M. leprae population driven by allelic drift associated with a
waning European leprosy epidemic would seem more
plausible.
Conclusion
Through the study of bioarchaeology and specifically an-
cient DNA, we are gaining a greater understanding of the
medieval European leprosy epidemic. By concentrating on
a single well-characterized site typical of British leprosaria,
St Mary Magdalen near Winchester, we have gained a de-
tailed and almost personal insight into the wider epidemic
and how it changed across the centuries. Our findingsreveal that at this site during the 11th century, leprosy
strains were typically part of a closely related group of type
2F strains, not the type 3 strains that predominate in later
European samples.
Methods
Bone retrieval and methods
The skeletons were excavated between 2009 and 2011 by a
team from the University of Winchester. The burials were
recovered as articulated remains from single graves and as-
sociated grave fills were subject to 100% sampling. Patho-
logical conditions were recorded and photographed in
detail and diagnosed with reference to appropriate sources
[11,12]. All necessary permits were obtained for the de-
scribed field studies, including a licence (−0070) to exhume
and retain human remains, provided by the Ministry of
Justice, 102 Petty France, London, SW1H 9AJ.
Bone sampling and DNA extraction
Samples of bone were taken from the rhino-maxillary
region of skeletons Sk14 and Sk27 to maximize the chances
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minimize the opportunities for cross-contamination be-
tween cases and, use of modern DNA as a positive control
was avoided completely [10]. The vomer region of a skel-
eton, Sk12, with no signs of leprosy was sampled as a nega-
tive control and was treated identically to the other samples
throughout. The bones were ground to a fine powder and
DNA extracted using the NucliSens™ extraction kit (bio-
Mériux Limited, Boxtel, The Netherlands) as described pre-
viously [13] in laboratories physically separate from rooms
in which leprosy DNA has been previously amplified.
PCR amplification of specific loci
Real-time PCR assays were carried out on a Mx3005P
qPCR system (Agilent Technologies, Wokingham, UK).
Methods for the PCR amplification of the multi-copy
RLEP locus, the single copy locus coding for the 18 kDa
antigen (ML1795), and for the M. tuberculosis specific
multi-copy loci IS1081 locus are all described by Taylor,
2013 [10].
Whole genome amplification, enrichment and analysis
DNA was extracted, enriched and sequenced either at
the University of Surrey alone, for Sk27, or independ-
ently at both the University of Surrey and University of
Tübingen for Sk14. Both protocols are fully described by
Schuenemann et al. [7]. Both involved removing uracil
residues with USER enzyme (New England Biolabs,
Hitchin, UK), repairing the DNA, ligating linkers to the
ends, and PCR amplifying before enriching for M. leprae
sequences using microarrays (once at the University of
Tübingen and twice at the University of Surrey). Sam-
ples were pair-end sequenced with double indices on
HiSeq2000 or MiSeq machines.
At the University of Surrey, reads were quality con-
trolled and aligned to the M leprae TN genome [9] using
Bowtie2 [24]. Duplicate reads were removed with Mark-
Duplicate script [25] and SNPs assigned. The criteria for
inclusion in the SNP/indel list were that polymorphs
had to be outside of annotated repeat regions, to have a
read depth of more than 5 reads in the sample, but less
than 5 reads in the control sample Sk12, have a QUAL
score of > =50 (not required for longer indels) and ap-
pear in more than 80% of reads. Indels had an additional
requirement that all qualifying reads had to span the
indel.
At the University of Tübingen the reads were first
quality controlled using FastQC, followed by adapter
clipping, merging of corresponding paired-end reads
and, finally, quality trimming of the resulting reads. The
reads were mapped against the M. leprae TN genome as
a reference using the Burrows-Wheeler Aligner (BWA).
Mapped reads were subject to duplicate removal using
Samtools’ rmdup method. The Genome Analysis Toolkit(GATK) was then used to generate a mapping assembly
and to call SNPs for each strain. The TN reference base
was called if the quality score was at least 30 and the
position was covered by at least 5 reads. A variant pos-
ition (SNP) was called if the position was covered by at
least 5 reads and the fraction of mapped reads contain-
ing the SNP was at least 90%.
To be included in phylogenetic analysis, SNPs had to
either be identified at both centers, or identified at only
one center, with no contradictory data from the other.
Phylogenetic analysis were carried using MEGA5 [26]
using Maximum Likelihood (using the Tamura-Nei
model), Maximum Parsimony (using Max-mini Branch-
&-bound algorithm) and Neighbour-Joining (using the
number of differences method) methods.
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